Logo CICANCER
Intranet Colaborate

Old CIC Events

Feedback loops controlling migration and invasion in healthy and cancerous cells 07/03/2019

Feedback loops controlling migration and invasion in healthy and cancerous cells

Laura Machesky — Beatson Institute [Glasgow, UK]

Thirty years of biochemistry ,of the small GTPases of the RHO family: 
Current status, challenges, and future directions 28/02/2019

Thirty years of biochemistry ,of the small GTPases of the RHO family: 
Current status, challenges, and future directions

Reza Ahmadian — Heinrich Heine University [Dusseldorf, Germany]

Nuevas terapias con actividad anti-tumoral en células madre tumorales de sarcomas 26/02/2019

Nuevas terapias con actividad anti-tumoral en células madre tumorales de sarcomas

René Rodríguez — Instituto de Investigación Sanitaria del Principado de Asturias (ISPA) /Hospital Universitario Central de Asturias (HUCA)

An epigenetic journey into the origin and evolution of B cell tumors 21/02/2019

An epigenetic journey into the origin and evolution of B cell tumors

José Ignacio Martín Subero — IDIBAPS, Universidad de Barcelona [Barcelona]

Clonal evolution of pre-malignant B-cells in the absence of AID 14/02/2019

Clonal evolution of pre-malignant B-cells in the absence of AID

Guillermo Rodríguez-Hernández — Centro de Investigación del Cáncer, CIC-IBMCC, lab.13

Role of microRNAs in B cell differentiation and neoplastic transformation. 12/02/2019

Role of microRNAs in B cell differentiation and neoplastic transformation.

Virginia García de Yébenes Mena — Centro Nacional de Investigaciones Cardiovasculares (CNIC). Madrid

Enhancer defects in acute myeloid leukemia (AML): The Evil-side of gene regulation 07/02/2019

Enhancer defects in acute myeloid leukemia (AML): The Evil-side of gene regulation

Ruud Delwel — Erasmus MC hospital  [Rotterdam, Netherlands]

Nuevas dianas terapéuticas y papel de la medicina de precisión en inmunooncología 31/01/2019

Nuevas dianas terapéuticas y papel de la medicina de precisión en inmunooncología

Víctor Moreno — Director, Clinical Research Phase 1 Trials Unit START MADRID-FJD, Hospital Fundación Jiménez Díaz

Desarrollo de nuevas estrategias para diagnóstico y clasificación de inmunodeficiencias predominantemente de anticuerpos 24/01/2019

Desarrollo de nuevas estrategias para diagnóstico y clasificación de inmunodeficiencias predominantemente de anticuerpos

Elena Blanco Álvarez — Centro de Investigación del Cáncer (CIC-IBMCC), lab. 11 Salamanca

Secreted factors and their role in Regeneration: Discovery and Therapeutic Applications 21/01/2019

Secreted factors and their role in Regeneration: Discovery and Therapeutic Applications

Pilar Ruiz Lozano — Regencor, Inc. y del Departamento de Pediatría (Cardiología) de la Stanford University School of Medicine, California (USA)

Chromatin Conformation in Development and Disease 17/01/2019

Chromatin Conformation in Development and Disease

Juan Manuel Vaquerizas — Max Planck Institute for Molecular Biomedicine [Münster, Germany]

Short-term activation of the Jun-N terminal Kinase pathway in apoptosis-deficient cells of Drosophila induces tumorigenesis 15/01/2019

Short-term activation of the Jun-N terminal Kinase pathway in apoptosis-deficient cells of Drosophila induces tumorigenesis

Noelia Pinal Seoane — Centro de Biología Molecular "Severo Ochoa" (CBMSO) de Madrid